Cordance Medical is developing a focused ultrasound system that enables precision medicine to brain diseases. We accomplish this by opening the blood-brain barrier (BBB), extending life by accelerating drug approvals, and enabling liquid biopsy (blood) tests to provide a real-time view of the tumor biology. Our platform allows us to open the BBB precisely to physician-directed regions of the brain (e.g., tumor site, amyloid plaque) in a simple, non-invasive 30-minute clinic procedure. Extensive pre-clinical and clinical investigations have demonstrated the safety and efficacy of the focused ultrasound technology at opening the BBB. Cordance has developed a strong IP position enabling a painless, quick, and outpatient product deployment to meet the needs of the community. The company seeks to raise a seed round to fund the company through all pre-clinical activities enabling pivotal human studies next year. Our platform is applicable for glioblastoma (GBM), brain metastasis, Alzheimer's, Parkinson's, epilepsy and mental health.
Location: United States, California, Mountain View
Employees: 11-50
Total raised: $8M
Founded date: 2018
Investors 4
| Date | Name | Website |
| - | Airstream ... | airstream.... |
| - | Angel Phys... | angelphysi... |
| 08.07.2022 | Creative D... | creativede... |
| - | Endless Fr... | endlessfro... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.11.2025 | Seed | $8M | - |
Mentions in press and media 4
| Date | Title | Description |
| 24.11.2025 | Cordance Medical Announces an Oversubscribed $8M Seed Financing | MOUNTAIN VIEW, CA, Cordance Medical, a pioneer in noninvasive focused ultrasound technology for brain disease treatment, announced an oversubscribed seed financing round surpassing its $8M target. >> Click here for more funding data ... |
| 24.11.2025 | Cordance Medical Raises $8M in Seed Funding | Cordance Medical, a Mountain View, CA-based medtech company leveraging ultrasound technology for brain disease treatment, raised $8M in Seed funding. The round was led by Sonder Capital with participation from Shanda Grab Ventures, Angel Ph... |
| 24.11.2025 | Shanda Group Participates in Cordance Medical’s Oversubscribed $8M Seed Financing to Advance Focused Ultrasound Platform for Brain Disease Treatment | We are excited to join Cordance Medical’s oversubscribed $8M seed round led by Sonder Capital, and including, Angel Physicians Fund, R42 Group, The Sontag Foundation Innovation Fund, and the Brain Tumor Investment Fund. Cordance Medical is ... |
| - | Cordance Medical | “Improving outcomes for patients with brain diseases” |